ARCHIVES

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

NCI begins rewrite of cancer center grant guidelines; will allow clinical investigator support. Goal is to implement P30-P50 working group recommendations, simplify guidelines, Karen Antman tells advisory board.

March 19, 2004

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

RFA/PA/Drug Group Announcement Limited

May 6, 1988

Wittes, Fraumeni Appointed As Division Directors

February 9, 1996

In Brief: Blumberg to direct NASA Astrobiology Institute’ Hopkins To Get $20M Donation

May 28, 1999